본문 바로가기
KERD
논문KCI 등재

Successful Early Clozapine Trial in the Treatment of First-episode Schizophrenia: A Case Report

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Clozapine remains the treatment of choice in refractory schizophrenia despite its various requirement to prescribe, such as mandatory blood monitoring program and various metabolic complication. Currently, clozapine is recommended only after two failed adequate antipsychotics trials. We report a case of a successful early clozapine trial in the treatment of first-episode schizophrenia patient, considering poor treatment response and repeated self-injurious behavior. This case highlights the efficacy of an early clozapine trial as a second-line treatment for first-episode schizophrenia in contrast to switching or combination treatment strategy.

Abstract

Clozapine remains the treatment of choice in refractory schizophrenia despite its various requirement to prescribe, such as mandatory blood monitoring program and various metabolic complication. Currently, clozapine is recommended only after two failed adequate antipsychotics trials. We report a case of a successful early clozapine trial in the treatment of first-episode schizophrenia patient, considering poor treatment response and repeated self-injurious behavior. This case highlights the efficacy of an early clozapine trial as a second-line treatment for first-episode schizophrenia in contrast to switching or combination treatment strategy.

참고문헌 (9)

  1. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders, "Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders", Aust N Z J Psychiatry, 39, pp.1~30 (2005)
  2. Alphs LD, "Clozapine: the commitment to patient safety", J Clin Psychiatry, 60(Suppl 12), pp.39~42 (1999)
  3. Henderson DC, "Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study", J Clin Psychiatry, 66, pp.1116~1121 (2005)
  4. Remington G, "Clozapine's role in the treatment of first-episode schizophrenia", Am J Psychiatry, 170, pp.146~151 (2013)
  5. Green AI, "Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients", Harv Rev Psychiatry, 3, pp.1~9 (1995)
  6. Lieberman J, "Treatment outcome of first episode schizophrenia", Psychopharmacol Bull, 25, pp.92~96 (1989)
  7. Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
  8. Freudenreich O, "Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects", Clin Schizophr Relat Psychoses, 6, pp.115~121 (2012)
  9. Sanz-Fuentenebro J, "Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: results after one year", Schizophr Res, 149, pp.156~161 (2013)

이 간행물의 다른 논문 (9건)